Patient Navigation for Colorectal Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to assist individuals in completing colonoscopies for colorectal cancer screening. It employs patient navigation, where trained guides support participants through phone calls, texts, and emails. The researchers aim to determine if this approach can boost screening rates, particularly in rural areas. Suitable candidates have been referred for a colonoscopy in the past three months, possibly following an abnormal stool test. As an unphased study, this trial provides a unique opportunity to contribute to innovative strategies that could enhance cancer screening accessibility.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this patient navigation program is safe for increasing colonoscopy completion?
Research shows that patient navigation is generally safe. This service helps patients obtain necessary medical tests. Studies have found that it increases the number of people screened for colorectal cancer, aiding them in completing colonoscopy appointments.
No evidence suggests that patient navigation causes harm. It primarily involves phone calls, texts, and emails to support patients. Without drugs or medical procedures, it avoids side effects associated with medicines.
Overall, evidence indicates that patient navigation assists patients without causing harm. It is a supportive service that simplifies healthcare management.12345Why are researchers excited about this trial?
Researchers are excited about the Patient Navigation intervention for colorectal cancer screening because it offers a personalized approach to help patients complete their colonoscopy screenings. Unlike standard educational brochures, this method uses trained navigators who provide support in the patient's preferred language through phone calls, texts, and emails. This tailored communication aims to address barriers to screening, potentially leading to higher completion rates and earlier detection of colorectal cancer.
What evidence suggests that patient navigation is effective for increasing colonoscopy completion for colorectal cancer screening?
Research has shown that patient navigation programs can increase colorectal cancer screening rates. In this trial, participants in the Patient Navigation Intervention arm will receive language-concordant assistance from a trained navigator to help complete colonoscopy screenings. One study found that a program combining mailed information and patient support increased screening by 7.3% compared to regular care. Patient navigation helps individuals overcome obstacles such as scheduling appointments or understanding the screening process. This method has also proven effective for breast and cervical cancer screenings. Overall, patient navigation effectively boosts participation in cancer screening programs.12678
Who Is on the Research Team?
Allison M Cole, MD, MPH
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for rural residents aged 45-75 who've been referred for a colonoscopy as part of colorectal cancer screening within the last three months. It's not open to those who've already had a colonoscopy since referral, live long-term in institutions (if over 65), are on hospice care, or have had colorectal cancer or total colectomy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Patient Navigation Intervention
Participants receive language-concordant patient navigation from a trained navigator to assist in completing colonoscopy
Usual Care Control
Participants receive an educational brochure about the importance of colonoscopy
Follow-up
Participants are monitored for colonoscopy completion and program effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- Patient Navigation
- Usual Care Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Cancer Institute (NCI)
Collaborator